Bibliography

Export 8 results:

Filters: Keyword is Immunosuppression / methods [Clear All Filters]

2006

Marubashi S, Dono K, Miyamoto A, Takeda Y, Nagano H, Umeshita K, et al. Liver transplantation for hepatitis C. J Hepatobiliary Pancreat Surg. 2006;13(5):382-92.

2005

Woodle ES, Susskind B, Alloway RR, Hanaway MJ, Thomas M, Buell J, et al. Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc. 2005;37(2):809-11.

2003

Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation. 2003;76(9):1289-93.

Chui AK, Chan CJ, Rao AR, Wong J, Chan FK, Chan HL, et al. Immunosuppression with rapid steriod reduction among predominantly HBV liver transplantation recipients: initial experience. Transplant Proc. 2003;35(1):419-20.

1999

Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208-16.

1998

Meignin V, Devergie A, Brice P, Brison O, Parquet N, Ribaud P, et al. Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia. Transplantation. 1998;65(4):595-7.

1991

Penn I. The changing pattern of posttransplant malignancies. Transplant Proc. 1991;23(1 Pt 2):1101-3.

1989

First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, et al. Successful retreatment of allograft rejection with OKT3. Transplantation. 1989;47(1):88-91.